Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

PaperCitations, authors & open-access status

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,652 citations, 2018 year and bronze oa status.

2,652
Citations
2018
Year
bronze
OA Status

Related on ScholarIQ

Norman Wolmark
Author
New England Journal of Medicine
Journal
HER2/EGFR in Cancer Research
Topic
HER2/EGFR in Cancer Research
Topic
Breast Cancer Treatment Studies
Topic
Cancer Treatment and Pharmacology
Topic
470M+ articles · free account